Indivisor names Joe Ciaffoni CEO; proposes incentive plan with share price targets up to $35

Indivior Pharmaceuticals, Inc.

Joe Ciaffoni to become CEO effective upon shareholder approval of new Directors' Remuneration Policy at May 8, 2025 AGM.
On-hire PSU award up to 1.575M shares vests based on VWAP targets: $15, $20, $25, $30, $35 over 1–5 years.
On-hire RSU award of 525,000 shares with cliff vest on 3rd anniversary of start date.
Proposed policy increases LTIP on-target grant to 400% of salary in 2026 and 700% in 2027.
Benchmarked vs US biopharma peers; CEO's potential dilution <2% of value created for shareholders.

item 7.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001625297-25-000025
form_type: 8-K
ticker: INDV
cik: 0001625297
company_name: Indivior Pharmaceuticals, Inc.
filed_at: 2025-03-27T23:59:59+00:00
discovered_at: 2026-05-14T18:03:04.229273+00:00
generated_at: 2026-05-24T03:56:01.837795+00:00
sec_items: ["7.01", "9.01"]
event_type: leadership
sentiment: positive
materiality_score: 0.75
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001625297-25-000025
json_url: https://secwatch.observer/filing/0001625297-25-000025.json
markdown_url: https://secwatch.observer/filing/0001625297-25-000025.md
text_url: https://secwatch.observer/filing/0001625297-25-000025.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1625297/000162529725000025/0001625297-25-000025-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1625297/000162529725000025/indv-20250327.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001625297-25-000025

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.